Skip to content
← Back to this collection

PUBLICATIONS · 23683550

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2013 Aug
First author
Weeda VB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Weeda VB
      type
      Author
    2. name
      Murawski M
      type
      Author
    3. name
      McCabe AJ
      type
      Author
    4. name
      Maibach R
      type
      Author
    5. name
      Brugières L
      type
      Author
    6. name
      Roebuck D
      type
      Author
    7. name
      Fabre M
      type
      Author
    8. name
      Zimmermann A
      type
      Author
    9. name
      Otte JB
      type
      Author
    10. name
      Sullivan M
      type
      Author
    11. name
      Perilongo G
      type
      Author
    12. name
      Childs M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Weeda VB
      type
      Author
    2. name
      Murawski M
      type
      Author
    3. name
      McCabe AJ
      type
      Author
    4. name
      Maibach R
      type
      Author
    5. name
      Brugières L
      type
      Author
    6. name
      Roebuck D
      type
      Author
    7. name
      Fabre M
      type
      Author
    8. name
      Zimmermann A
      type
      Author
    9. name
      Otte JB
      type
      Author
    10. name
      Sullivan M
      type
      Author
    11. name
      Perilongo G
      type
      Author
    12. name
      Childs M
      type
      Author
    bibliography ids
    1. nci-bib-7ed7eef07d2dc5af85c679de
    book metadata
    content sha256
    5feb9f99ab301f988270767958618c849d287cb4c973dd4ebb57ece4fc7330db
    document type
    citation
    dois
    1. 10.1016/j.ejca.2013.04.012
    electronic publication date
    display
    2013 May 15
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23683550
    immutable id
    pubmed:23683550@5feb9f99ab301f988270767958618c849d287cb4c973dd4ebb57ece4fc7330db
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    12
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    2698-704
    volume
    49
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23683550
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      9179dc73ddae53ef10f5b387f2a9523170b96f1ed81d76a3a5f1b37d3086d25d
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 Aug
      precision
      month
      year
      2013
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23683550/
      title
      Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

      Preserved source evidence · Not medical advice